Stephanie L. Safgren

Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes

Matthew P. Goetz, James M. Rae, Vera J. Suman et al. · Journal of Clinical Oncology · 2005 · 786 citations · Full text

Medicine, Oncology, Pharmacology +16

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

Matthew P. Goetz, Stacey K. Knox, Vera J. Suman et al. · Breast Cancer Research and Treatment · 2006 · 550 citations

Medicine, Pharmacokinetics, Pharmacology +14

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent

Chitta Ranjan Patra, Resham Bhattacharya, Enfeng Wang et al. · Cancer Research · 2008 · 368 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer

Matthew P. Goetz, David O. Toft, Joel M. Reid et al. · Journal of Clinical Oncology · 2005 · 334 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Gemcitabine and Cytosine Arabinoside Cytotoxicity: Association with Lymphoblastoid Cell Expression

Liang Li, Brooke L. Fridley, Krishna R. Kalari et al. · Cancer Research · 2008 · 177 citations · Full text

Medicine, Oncology, Pharmacology +17